Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

被引：0
|
作者：
Freiberg-Richter, Jens [1 ]
Hantzschel, Ingmar [1 ]
Jenke, Andreas [1 ]
Lorenz, Petra [1 ]
Ehninger, Gerhard [1 ]
Bornhaeuser, Martin [1 ]
机构：
[1] Univ Hosp, Med Clin 1, Dresden, Germany
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
756
引用
收藏
页码：227A / 227A
页数：1
相关论文
共 50 条
  • [31] Impact of adding mycophenolate mofetil (MMF) to cyclosporine (CSA) as prophylaxis for acute graft versus host disease (GVHD) following nonmyeloablative allogeneic peripheral blood stem cell (PBSC) transplantation.
    Chakrabarti, S
    Srinivasan, R
    Geller, N
    Abo-Zena, RA
    Marquesen, M
    Goodwin, R
    Donohue, T
    Dunbar, C
    Young, NS
    Leitman, SF
    Read, EJ
    Bolan, CD
    Barrett, AJ
    Childs, R
    BLOOD, 2002, 100 (11) : 419A - 420A
  • [32] Immunosuppressive therapy for prophylaxis of graft-versus-host disease in pediatric allogeneic stem cell transplantation
    Ozturk, Gulyuz
    Tagcu, Deniz
    Atay, Didem
    Akcay, Arzu
    Garipardyc, Mesut
    Anak, Sema
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 504 - 504
  • [33] Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Smith, TL
    Folloder, J
    Khouri, I
    Ueno, NT
    Mehra, R
    Körbling, M
    Huh, YO
    Giralt, S
    Gajewski, J
    Donato, M
    Cleary, K
    Claxton, D
    Braunschweig, I
    van Besien, K
    Andersson, BS
    Anderlini, P
    Champlin, R
    BLOOD, 1999, 94 (04) : 1465 - 1470
  • [34] Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?
    Koc, H
    Gurman, G
    Arslan, O
    Ozcan, M
    Akan, H
    Ilhan, O
    Konuk, N
    Beksac, M
    Uysal, A
    BLOOD, 1996, 88 (06) : 2362 - 2364
  • [35] A pilot study of mycophenolate mofetil for the prophylaxis and treatment of graft-versus-host disease
    Luo, Chengwei
    Du, Xin
    Weng, Jianyu
    Guo, Rong
    Lu, Zesheng
    BLOOD, 2007, 110 (11) : 319B - 319B
  • [36] Clinical impact of hyperacute graft-versus-host disease on the results of allogeneic stem cell transplantation.
    Sohn, SK
    Kim, DH
    Kim, JG
    Sung, WJ
    Suh, KW
    Suh, JS
    Lee, KS
    Lee, KB
    BLOOD, 2003, 102 (11) : 445B - 446B
  • [37] Mycophenolate mofetil AUC targeting for GvHD prophylaxis after allogeneic haematopoetic stem cell transplantation
    Freiberg-Richter, J
    Jenke, A
    Pursche, S
    Bonin, M
    Schleyer, E
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S147 - S147
  • [38] Mycophenolate mofetil for treatment of graft-versus-host disease following stem cell transplantation when cyclosporine is contraindicated
    Rzepecki, P
    Batiuk, B
    Zolnierek, J
    Sarosiek, T
    Bartczak, E
    Szczylik, C
    BONE MARROW TRANSPLANTATION, 2004, 33 : S310 - S310
  • [39] Successful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis
    Okamura, Atsuo
    Yakushijin, Kimikazu
    Inui, Yumiko
    Funakoshi, Yohei
    Kawamori, Yuriko
    Shimada, Takanobu
    Toyoda, Masanori
    Chayahara, Naoko
    Kiyota, Naomi
    Fujiwara, Yutaka
    Mukohara, Toru
    Matsuoka, Hiroshi
    Yamamoto, Katsuya
    Minami, Hironobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (06) : 765 - 770
  • [40] Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings
    Vogelsang, GB
    Arai, S
    BONE MARROW TRANSPLANTATION, 2001, 27 (12) : 1255 - 1262
12345